Nantahala Capital Management - SILVERBACK THERAPEUTICS INC ownership

SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 71 filers reported holding SILVERBACK THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Nantahala Capital Management ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,154,504
+244.3%
1,099,075
+510.3%
0.36%
+203.4%
Q2 2023$1,206,650
-81.7%
180,097
-85.6%
0.12%
-72.6%
Q3 2022$6,599,000
+12.3%
1,249,863
-9.8%
0.43%
+44.7%
Q2 2022$5,877,000
+86.5%
1,386,138
+51.7%
0.30%
+112.2%
Q1 2022$3,152,000
-53.0%
913,597
-9.2%
0.14%
-41.1%
Q4 2021$6,703,000
-45.2%
1,006,462
-17.9%
0.24%
-38.9%
Q3 2021$12,242,000
-68.7%
1,226,631
-3.1%
0.39%
-65.3%
Q2 2021$39,115,000
-8.4%
1,266,266
+27.6%
1.11%
-11.0%
Q1 2021$42,697,000
-21.5%
992,242
-17.8%
1.25%
-25.9%
Q4 2020$54,384,0001,206,4711.68%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 4,012,903$15,168,7737.77%
Nextech Invest Ltd. 1,910,029$7,219,9102.19%
K2 PRINCIPAL FUND, L.P. 2,552,062$9,646,7942.02%
Charles Schwab Trust Co 4,246,071$16,050,1481.81%
Sio Capital Management, LLC 1,105,911$4,180,3441.29%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 11,077,927$41,874,5640.92%
SECTORAL ASSET MANAGEMENT INC 1,049,191$3,965,9420.77%
Orbimed Advisors 9,240,887$34,930,5530.74%
RA Capital Management 9,459,678$35,757,5830.70%
K2 PRINCIPAL FUND, L.P. 688,900$2,604,0420.55%
View complete list of SILVERBACK THERAPEUTICS INC shareholders